Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 3, 1998, Pages 195-202

  Schønning, Kristian ^a   Joost, Mette ^a   Gram, Gregers J ^a   Machuca, Roberto ^b   Nielsen, Claus ^b   Nielsen, Jens Ole ^a   Hansen, John Erik Stig ^a,c  

^a STENO DIABETES CENTER   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Autologous neutralizing antibody response; Chemokine receptor polymorphism; Long term HIV 1 infection

Indexed keywords

CHEMOKINE RECEPTOR; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; GENE DELETION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; VIRUS ISOLATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032125536     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199807010-00001     Document Type: Article

References (31)

1. Cao Y. Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
2. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl J Med 1995;332:209-16.
3. Schønning K, Nielsen C, Iversen J, Nielsen JO, Hansen JES. Neutralizing antibodies in slowly progressing HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:400-7.
4. Albert J, Abrahamsson B, Nagy K, et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990;4:107-12.
5. Tremblay M, Wainberg MA. Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. J Infect Dis 1990;162:735-7.
6. Arendrup M, Nielsen C, Hansen JES, Pedersen C, Mathiesen L, Nielsen JO. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development escape virus neutralizing antibodies. J Acquir Immune Defic Syndr 1992;5:303-7.
7. Tersmette M, Gruters RA, de Goede REY, et al. Evidence for a role of virulent human immunodeficiency virus isolates in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989;63:2118-25.
8. + cell depletion and progression to AIDS. Ann Intern Med 1992;118.681-8.
9. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
10. Seng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;272:661-6.
11. + cell is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
12. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
13. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
14. Simmons G, Wilkinson D, Reeves JD, et al. Primary, syncytuim-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996:70:8355-60.
15. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
16. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
17. Eugen-Olsen J, Iversen AKN, Garred P, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;11:305-10.
18. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-40.
19. + lymphocytes. J Virol Methods 1991;35: 15-25.
20. Leitner T, Korovina G, Marquina S, Smolskaya T, Albert J. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant. AIDS Res Hum Retroviruses 1996;12:1595-603.
21. Fouchier RA, Brouwer M, Broersen SM, Schuitemaker H. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J Clin Microbiol 1995;33: 906-11.
22. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
23. Hansen JES, Nielsen C, Arendrup M, et al. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J Virol 1991;65:6461-7.
24. + T-cell levels. AIDS 1993;7:1159-66.
25. Pellegrin I, Legrand E, Neau D, et al. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:438-47.
26. Moog C, Fleury HJA, Pellegrin I, Kim A, Aubertin AM. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J Virol 71:3734-41.
27. Parren PWHI, Burton DR, Sattentau QJ. HIV-1 antibody-debris or virion? Nature Med 1997;3:366-7.
28. Heath SL, Grant Tew J, Tew JG, Szakal AK, Burton GF. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995;377:740-4.
29. McKnight A, Weiss RA, Shotton C, Takeuchi Y, Hoshino H, Clapham PR. Change in tropism upon immune escape by human immunodeficiency virus. J Virol 1995;69:3167-70.
30. Weiss RA. HIV receptors and the pathogenesis of AIDS. Science 1996;272:1885-6.
31. Schreiber M, Wachsmuth C, Muller H, et al. Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression. J Gen Virol 1996;77:2403-2414.